Cite
HARVARD Citation
Quartier, P. et al. (2021). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & rheumatology. 73 (2), pp. 336-346. [Online].